Clinical Trial Update: Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating vaginal testosterone versus placebo to prevent recurrent urinary tract infections in women with vaginal atrophy or postmenopausal sympt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Disorder
• Urinary Tract Infection
• Vaginal Atrophy

Drugs mentioned

• Vaginal Testosterone (testosterone)

Snippet

Sponsor: Maimonides Medical Center | Conditions: Recurrent Urinary Tract Infection, Vaginal Atrophy | Phase 4 | Status: RECRUITING